Norethisterone 5mg Tablets for Period Delay - 30 or 60 Tablets — product packaging
Norethisterone 5mg Tablets for Period Delay - 30 or 60 Tablets — product packaging
Ways Pharmacy supplementary product information card for Norethisterone 5mg Tablets for Period Delay - 30 or 60 Tablets
Ways Pharmacy 微至药房产品信息卡(中文版):Norethisterone 5mg Tablets for Period Delay - 30 or 60 Tablets
Norethisterone 5mg Tablets for Period Delay - 30 or 60 Tablets — product packaging
Norethisterone 5mg Tablets for Period Delay - 30 or 60 Tablets — product packaging
Ways Pharmacy supplementary product information card for Norethisterone 5mg Tablets for Period Delay - 30 or 60 Tablets
Ways Pharmacy 微至药房产品信息卡(中文版):Norethisterone 5mg Tablets for Period Delay - 30 or 60 Tablets
库存仅剩-59 售罄

炔诺酮(Norethisterone) 5mg 女性推迟月经延迟例假,最多延迟17天,考试旅行重要日子必备 (图片仅供参考,随机包装发货)period delay pill

£19.99 £19.99 售罄
- +
This is a prescription product provided through pharmacist assessment under an approved treatment plan.
Continue to Assessment
存货单位 WY0033130S
£50 Voucher for Hino Travel with every purchase over £50
Frequently Asked Questions
使用诺乙酯(Norethisterone)推迟月经周期的安全注意事项有哪些?
chevron-down
是的——严格按照指示服用炔诺酮,通常在月经预计来潮前 3 天开始服用,并持续最长可达 14 天。避免漏服以保持其有效性。若需个性化方案和获批的治疗,点击「开始咨询」以安全开启用药。
线上订购乙炔酮后的过程为何?
chevron-down
一旦您开始咨询并选择及支付治疗费用,我们的团队将审核您的评估结果,以确保诺乙炔酮(Norethisterone)适合您。若所选药物不适合,药剂师将推荐替代方案。经批准后,您的订单将直接发货,无需您进行任何额外操作。
谁可以服用诺乙炔酮,谁该避免服用?
chevron-down
诺乙炔酮适用于大多数健康女性,但不建议用于有血栓病史、肝病或激素敏感性疾病的女性。为了确保其对您安全,请开始咨询并完成简短的健康评估。如果不适合,我们的药剂师将提供适当的替代方案。
诺乙炔酮是如何延迟月经的?
chevron-down
诺乙炔酮通过维持高水平的孕酮,防止子宫内膜脱落,从而有效推迟月经。通常在月经来潮前几天开始,每日服用三次。开始咨询,选择您的治疗方案,在我们的团队确认一切安全后,药物将直接寄送,无需进一步操作。
诺乙炔是什么,它有什么用途?
chevron-down
诺乙炔酮5毫克是一种合成激素,用于推迟月经、治疗月经过多或管理其他月经紊乱。它通过模拟天然激素孕酮的作用,帮助调节您的月经周期。开始治疗时,只需点击“开始咨询”,选择并支付您的药物,我们的行政团队将审核您的订单以确保安全性和适用性。
Reviewed by
Chenyang Ma
Chenyang Ma
MPharm
Superintendent Pharmacist
Chenyang Ma is a GPhC-registered Superintendent Pharmacist at Ways Pharmacy in London. With a Master of Pharmacy (MPharm) from the University of Nottingham (2013), he combines strong commercial acumen and clinical expertise to drive patient-centric pharmacy services.
Reviewed Date
04 June 2025
Next Review
04 June 2026
Published On
04 June 2025
Last Updated
04 June 2025